Evidence map›Paper›PMID 32630389›Full record

ArticleMetabolites2020

Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening.

Anna Maria A P Fernandes, Marcia C F Messias, Gustavo H B Duarte, Gabrielle K D de Santis, Giovana C Mecatti, Andreia M Porcari, Michael Murgu, Ana Valéria C Simionato, Thalita Rocha, Carlos A R Martinez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Metabolites · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Potential Role of Plasmalogens in the Modulation of Biomembrane Morphology.Frontiers in cell and developmental biology · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anna Maria A P FernandesLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0002-7489-7637
Marcia C F MessiasLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Gustavo H B DuarteInstitute of Chemistry (IQ), University of Campinas (UNICAMP), Campinas, São Paulo 13083-970, Brazil.
Gabrielle K D de SantisLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Giovana C MecattiLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Andreia M PorcariLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0003-4244-8594
Michael MurguLuiz Barssotti Application Laboratory, Waters Technologies from Brazil, Barueri, São Paulo 06455-020, Brazil.
Ana Valéria C SimionatoNational Institute of Science and Technology in Bioanalytics, IQ, UNICAMPCampinas, São Paulo 13083-970, Brazil.
Thalita RochaLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0002-2731-9586
Carlos A R MartinezLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Patricia O CarvalhoLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0002-2681-7022
Universidade São Francisco · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance Code 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/13317-6 and 2017/25017-4
6 · The paper itself

Abstract

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10-15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagnosis. We used ultra-performance liquid chromatography coupled to electrospray ionization quadrupole time-of-flight mass spectrometry operating in high energy collision spectral acquisition mode (MS

Indexed as

biomarkerscolon cancerlipidomicmass spectrometryplasmalogens

Identifiers

PMID32630389
PMCPMC7345851
OpenAlexW3037136069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.